Overview

Staccato Loxapine Single Dose PK

Status:
Completed

Trial end date:
2005-11-01

Target enrollment:

Participant gender:

Summary

The objective of this study was to assess the safety, tolerability and pharmacokinetics of a single inhaled dose of (administered in 1 or 2 puffs) Staccato Loxapine in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Treatments:

Loxapine